Quantitative Product X
Optimisation in MDD
The client...
Has a brand in clinical trials for their drug (X) to treat major depressive disorder (MDD) and were preparing for the phase III trials. The research enabled the clients to prepare a strategy for the clinical trials and set the groundwork for a marketing plan.
What we did was...
Online quantitative interviews (CAWI) lasting 45 mins were conducted with 125 prescribing physicians in each of US, UK, France, Germany, Italy and Spain. The physicians comprised of both PCPs and Psychiatrists and all prescribed from a wide variety of drugs to treat depression related disorders. The main research instrument was a trade off exercise using a discrete choice model exercise.
The outcome was...
As well as a final report covering all of the global and country specific findings, with respect to the physicians reactions to Product X, the clients were also delivered an Excel based simulator program which allowed them to map out certain "what if" scenarios based on the attributes that were used and evaluated during the discrete choice exercise.
Zaicom Research Plus, Fraser House, 14 Carfax, Horsham, West Sussex RH12 1DZ insight@zaicom.com. Zaicom.com is the trading name of Zaicom Research Plus Ltd. Zaicom Research Plus is a limited company registered in England and Wales with company number 4828260. Registered office: St James's House, 8 Overcliffe, Gravesend, Kent DA11 0HJ. VAT registration no: 818283318
